1BWC | A:18-160,A:290-365; A:161-289 | STRUCTURE OF HUMAN GLUTATHIONE REDUCTASE COMPLEXED WITH AJOENE INHIBITOR AND SUBVERSIVE SUBSTRATE |
1DNC | A:18-160,A:290-365; A:161-289 | HUMAN GLUTATHIONE REDUCTASE MODIFIED BY DIGLUTATHIONE-DINITROSO-IRON |
1GOS | A:4-41,A:63-78,A:211-289,A:403-463; B:4-41,B:63-78,B:211-289,B:403-463 | HUMAN MONOAMINE OXIDASE B |
1GRA | A:18-160,A:290-365; A:161-289 | SUBSTRATE BINDING AND CATALYSIS BY GLUTATHIONE REDUCTASE AS DERIVED FROM REFINED ENZYME: SUBSTRATE CRYSTAL STRUCTURES AT 2 ANGSTROMS RESOLUTION |
1GRB | A:18-160,A:290-365; A:161-289 | SUBSTRATE BINDING AND CATALYSIS BY GLUTATHIONE REDUCTASE AS DERIVED FROM REFINED ENZYME: SUBSTRATE CRYSTAL STRUCTURES AT 2 ANGSTROMS RESOLUTION |
1GRE | A:18-160,A:290-365; A:161-289 | SUBSTRATE BINDING AND CATALYSIS BY GLUTATHIONE REDUCTASE AS DERIVED FROM REFINED ENZYME: SUBSTRATE CRYSTAL STRUCTURES AT 2 ANGSTROMS RESOLUTION |
1GRF | A:18-160,A:290-365; A:161-289 | SUBSTRATE BINDING AND CATALYSIS BY GLUTATHIONE REDUCTASE AS DERIVED FROM REFINED ENZYME: SUBSTRATE CRYSTAL STRUCTURES AT 2 ANGSTROMS RESOLUTION |
1GRG | A:18-160,A:290-365; A:161-289 | SUBSTRATE BINDING AND CATALYSIS BY GLUTATHIONE REDUCTASE AS DERIVED FROM REFINED ENZYME: SUBSTRATE CRYSTAL STRUCTURES AT 2 ANGSTROMS RESOLUTION |
1GRT | A:18-160,A:290-365; A:161-289 | HUMAN GLUTATHIONE REDUCTASE A34E/R37W MUTANT |
1GSN | A:18-160,A:290-365; A:161-289 | HUMAN GLUTATHIONE REDUCTASE MODIFIED BY DINITROSOGLUTATHIONE |
1K4Q | A:18-160,A:290-365; A:161-289 | HUMAN GLUTATHIONE REDUCTASE INACTIVATED BY PEROXYNITRITE |
1M6I | A:129-169,A:212-261,A:403-476; A:172-204,A:265-397 | CRYSTAL STRUCTURE OF APOPTOSIS INDUCING FACTOR (AIF) |
1OJ9 | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 1,4-DIPHENYL-2-BUTENE |
1OJA | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH ISATIN |
1OJC | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE |
1OJD | A:4-41,A:63-78,A:211-289,A:403-463; B:4-41,B:63-78,B:211-289,B:403-463; C:4-41,C:63-78,C:211-289,C:403-463; D:4-41,D:63-78,D:211-289,D:403-463; E:4-41,E:63-78,E:211-289,E:403-463; F:4-41,F:63-78,F:211-289,F:403-463; G:4-41,G:63-78,G:211-289,G:403-463; H:4-41,H:63-78,H:211-289,H:403-463; I:4-41,I:63-78,I:211-289,I:403-463; L:4-41,L:63-78,L:211-289,L:403-463 | HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH LAURYLDIMETHYLAMINE-N-OXIDE (LDAO) |
1S2Q | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-PROPARGYL-1(R)-AMINOINDAN (RASAGILINE) |
1S2Y | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-PROPARGYL-1(S)-AMINOINDAN |
1S3B | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-METHYL-N-PROPARGYL-1(R)-AMINOINDAN |
1S3E | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH 6-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN |
1XAN | A:18-160,A:290-365; A:161-289 | HUMAN GLUTATHIONE REDUCTASE IN COMPLEX WITH A XANTHENE INHIBITOR |
1ZMC | B:4-152,B:279-350; A:153-278; B:153-278; C:153-278; D:153-278; E:153-278; F:153-278; G:153-278; H:153-278; C:4-152,C:279-350; F:4-152,F:279-350; H:4-152,H:279-350; A:3-152,A:279-350; E:3-152,E:279-350; G:3-152,G:279-350; D:1-152,D:279-350 | CRYSTAL STRUCTURE OF HUMAN DIHYDROLIPOAMIDE DEHYDROGENASE COMPLEXED TO NAD+ |
1ZMD | B:4-152,B:279-350; A:153-278; B:153-278; C:153-278; D:153-278; E:153-278; F:153-278; G:153-278; H:153-278; C:4-152,C:279-350; F:4-152,F:279-350; H:4-152,H:279-350; A:3-152,A:279-350; D:3-152,D:279-350; G:3-152,G:279-350; E:2-152,E:279-350 | CRYSTAL STRUCTURE OF HUMAN DIHYDROLIPOAMIDE DEHYDROGENASE COMPLEXED TO NADH |
1ZY8 | A:1-152,A:279-350; G:1-152,G:279-350; H:1-152,H:279-350; I:1-152,I:279-350; J:1-152,J:279-350; A:153-278; B:153-278; C:153-278; D:153-278; E:153-278; F:153-278; G:153-278; H:153-278; I:153-278; J:153-278; B:1-152,B:279-350; C:1-152,C:279-350; D:1-152,D:279-350; E:1-152,E:279-350; F:1-152,F:279-350 | THE CRYSTAL STRUCTURE OF DIHYDROLIPOAMIDE DEHYDROGENASE AND DIHYDROLIPOAMIDE DEHYDROGENASE-BINDING PROTEIN (DIDOMAIN) SUBCOMPLEX OF HUMAN PYRUVATE DEHYDROGENASE COMPLEX. |
2AAQ | A:18-160,A:290-365; A:161-289 | CRYSTAL STRUCTURE ANALYSIS OF THE HUMAN GLUTAHIONE REDUCTASE, COMPLEXED WITH GOPI |
2BK3 | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH FARNESOL |
2BK4 | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | HUMAN MONOAMINE OXIDASE B: I199F MUTANT IN COMPLEX WITH RASAGILINE |
2BK5 | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | HUMAN MONOAMINE OXIDASE B: I199F MUTANT IN COMPLEX WITH ISATIN |
2BXR | A:12-50,A:72-87,A:220-300,A:409-464; B:12-50,B:72-87,B:220-300,B:409-464 | HUMAN MONOAMINE OXIDASE A IN COMPLEX WITH CLORGYLINE, CRYSTAL FORM A |
2BXS | A:12-50,A:72-87,A:220-298,A:412-472; B:12-50,B:72-87,B:220-298,B:412-472 | HUMAN MONOAMINE OXIDASE A IN COMPLEX WITH CLORGYLINE, CRYSTAL FORM B |
2BYB | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH DEPRENYL |
2C64 | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | MAO INHIBITION BY RASAGILINE ANALOGUES |
2C65 | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | MAO INHIBITION BY RASAGILINE ANALOGUES |
2C66 | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | MAO INHIBITION BY RASAGILINE ANALOGUES |
2C67 | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | MAO INHIBITION BY RASAGILINE ANALOGUES |
2C70 | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS |
2C72 | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS |
2C73 | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS |
2C75 | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS |
2C76 | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS |
2CFY | A:11-165,A:292-368; B:11-165,B:292-368; C:11-165,C:292-368; D:11-165,D:292-368; E:11-165,E:292-368; F:11-165,F:292-368; A:166-291; B:166-291; C:166-291; D:166-291; E:166-291; F:166-291 | CRYSTAL STRUCTURE OF HUMAN THIOREDOXIN REDUCTASE 1 |
2F5Z | B:4-152,B:279-350; A:153-278; B:153-278; C:153-278; D:153-278; E:153-278; F:153-278; G:153-278; H:153-278; J:153-278; I:153-278; D:4-152,D:279-350; F:4-152,F:279-350; A:3-152,A:279-350; C:3-152,C:279-350; E:3-152,E:279-350; G:3-152,G:279-350; H:3-152,H:279-350; I:3-152,I:279-350; J:3-152,J:279-350 | CRYSTAL STRUCTURE OF HUMAN DIHYDROLIPOAMIDE DEHYDROGENASE (E3) COMPLEXED TO THE E3-BINDING DOMAIN OF HUMAN E3-BINDING PROTEIN |
2GH5 | A:18-160,A:290-365; B:18-160,B:290-365; A:161-289; B:161-289 | CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE REDUCTASE COMPLEXED WITH A FLUORO-ANALOGUE OF THE MENADIONE DERIVATIVE M5 |
2GRT | A:18-160,A:290-365; A:161-289 | HUMAN GLUTATHIONE REDUCTASE A34E, R37W MUTANT, OXIDIZED GLUTATHIONE COMPLEX |
2J3N | A:11-165,A:292-368; B:11-165,B:292-368; C:11-165,C:292-368; D:11-165,D:292-368; E:11-165,E:292-368; F:11-165,F:292-368; A:166-291; B:166-291; C:166-291; D:166-291; E:166-291; F:166-291 | X-RAY STRUCTURE OF HUMAN THIOREDOXIN REDUCTASE 1 |
2V5Z | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | STRUCTURE OF HUMAN MAO B IN COMPLEX WITH THE SELECTIVE INHIBITOR SAFINAMIDE |
2VRL | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | STRUCTURE OF HUMAN MAO B IN COMPLEX WITH BENZYLHYDRAZINE |
2VRM | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | STRUCTURE OF HUMAN MAO B IN COMPLEX WITH PHENYETHYLHYDRAZINE |
2VZ2 | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | HUMAN MAO B IN COMPLEX WITH MOFEGILINE |
2XFU | A:3-41,A:63-78,A:211-289,A:403-463; B:3-41,B:63-78,B:211-289,B:403-463 | HUMAN MONOAMINE OXIDASE B WITH TRANYLCYPROMINE |
2Z5X | A:12-50,A:72-87,A:220-298,A:412-472 | CRYSTAL STRUCTURE OF HUMAN MONOAMINE OXIDASE A WITH HARMINE |
2Z5Y | A:12-50,A:72-87,A:220-298,A:412-472 | CRYSTAL STRUCTURE OF HUMAN MONOAMINE OXIDASE A (G110A) WITH HARMINE |
3GRS | A:18-160,A:290-365; A:161-289 | REFINED STRUCTURE OF GLUTATHIONE REDUCTASE AT 1.54 ANGSTROMS RESOLUTION |
3GRT | A:18-160,A:290-365; A:161-289 | HUMAN GLUTATHIONE REDUCTASE A34E, R37W MUTANT, OXIDIZED TRYPANOTHIONE COMPLEX |
4GR1 | A:18-160,A:290-365; A:161-289 | THE BINDING OF THE RETRO-ANALOGUE OF GLUTATHIONE DISULFIDE TO GLUTATHIONE REDUCTASE |
4GRT | A:18-160,A:290-365; A:161-289 | HUMAN GLUTATHIONE REDUCTASE A34E, R37W MUTANT, MIXED DISULFIDE BETWEEN TRYPANOTHIONE AND THE ENZYME |
5GRT | A:18-160,A:290-365; A:161-289 | HUMAN GLUTATHIONE REDUCTASE A34E, R37W MUTANT, GLUTATHIONYLSPERMIDINE COMPLEX |